CORMEDIX INC. - COMMON

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12 Mar 2024 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Reimbursement Updates

30 Jan 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Commercial and Operational Updates

08 Jan 2024 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Appointment of Chief Legal Officer

15 Dec 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Partnership With The Leapfrog Group

04 Dec 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces FDA Approval of DefenCath® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

15 Nov 2023 11:57:47 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update

14 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023

02 Nov 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference

11 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference

26 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

08 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference

06 Sep 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath

30 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update

08 Aug 2023 06:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023

26 Jul 2023 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants

28 Jun 2023 21:57:02 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

28 Jun 2023 15:07:53 By Nasdaq GlobeNewswire

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath

21 Jun 2023 07:30:00 By Nasdaq GlobeNewswire